SCHEMBL4450458

SCHEMBL4450458

Nc1nc(-c2ccccc2)c2c(C3CCN(C(=O)Cc4c(Cl)cccc4Cl)CC3)cccc2n1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
DGAT1 O75907 1/20 0.42
ALDH1A1 P00352 3/20 0.40
HTT P42858 3/20 0.40
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 2/20 0.40
P2RX7 Q99572 1/20 0.39
CNR1 P21554 3/20 0.39
DRD1 P21728 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HBB P68871 1/20 0.39
DCPS Q96C86 2/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4134698 0.72 KMT2A (0.47) KMT2AMEN1DGAT1ALDH1A1HTT
SCHEMBL4450457 0.64 KMT2A (0.44) KMT2AMEN1DGAT1MAPTSMN1; SMN2
SCHEMBL6979861 0.64 ROCK1 (0.42) KMT2AMEN1ALDH1A1HTTSMN1; SMN2
SCHEMBL4130631 0.63 KMT2A (0.46) KMT2AMEN1DGAT1MAPTSMN1; SMN2
SCHEMBL4130629 0.63 KMT2A (0.46) KMT2AMEN1DGAT1ALDH1A1MAPT
SCHEMBL2636181 0.62 RBP4 (0.49) KMT2AMEN1
SCHEMBL27689684 0.62 ADORA2A (0.54) DCPS
SCHEMBL6981163 0.61 PARP1 (0.45) ALDH1A1HTTMAPTLMNAKDM4E
SCHEMBL6977139 0.61 PARP1 (0.45) ALDH1A1HTTMAPTLMNAKDM4E
SCHEMBL6970712 0.61 PARP1 (0.45) ALDH1A1HTTMAPTLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134695-A1 INHIBITORS OF THE HEDGEHOG PATHWAY Exelixis, Inc. (US) 2009-12-23 EP disclosed
WO-2008112913-A1 INHIBITORS OF THE HEDGEHOG PATHWAY EXELIXIS, INC. (US) 2008-09-18 WO disclosed